The association between air pollution exposure and glucose and lipids levels

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 6, 2016, Pages 2460-2467

  Sade, Maayan Yitshak ^a,b   Kloog, Itai ^a   Liberty, Idit F ^a,c   Schwartz, Joel ^d   Novack, Victor ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Asuta Medical Center   (Israel)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; TRIACYLGLYCEROL; AIR POLLUTANT; GLUCOSE BLOOD LEVEL;

ADULT; AIR POLLUTION; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PARTICULATE MATTER; PRIORITY JOURNAL; PROTECTION; RETROSPECTIVE STUDY; ADOLESCENT; ADVERSE EFFECTS; AGED; AIR POLLUTANT; ANALYSIS; BLOOD; CARDIOVASCULAR DISEASES; ISRAEL; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIR POLLUTANTS; AIR POLLUTION; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; ISRAEL; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIGLYCERIDES; YOUNG ADULT;

EID: 84973551303     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1378     Document Type: Article

References (41)

1. Lim SS, Vos T, Flaxman AD. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010 (vol 380, pg 2224, 2012). Lancet. 2013;381:1276-1276.
2. Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010; 121:2331-2378.
3. Baïz N, Dargent-Molina P, Wark JD, et al. Gestational exposure to urban air pollution related to a decrease in cord blood vitamin d levels. J Clin Endocrinol Metab. 2012;97:4087-4095.
4. Miller MR, Shaw CA, Langrish JP. From particles to patients: oxidative stress and the cardiovascular effects of air pollution. Future Cardiol. 2012;8:577-602.
5. Araujo J A. Particulate air pollution, systemic oxidative stress, inflammation, and atherosclerosis. Air Qual Atmos Health. 2010;4: 79-93.
6. Campen MJ, Lund A, Rosenfeld M. Mechanisms linking trafficrelated air pollution and atherosclerosis. Curr Opin Pulm Med. 2012;18:155-160.
7. Emmerechts J, Jacobs L, Van Kerckhoven S, et al. Air pollutionassociated procoagulant changes: The role of circulating microvesicles. J Thromb Haemost. 2012;10:96-106.
8. Tan WC, Qiu D, Liam BL, et al. The human bone marrow response to acute air pollution caused by forest fires. Am J Respir Crit Care Med. 2000;161:1213-1217.
9. Yin F, Lawal A, Ricks J, et al. Diesel exhaust induces systemic lipid peroxidation and development of dysfunctional pro-oxidant and pro-inflammatory high-density lipoprotein. Arterioscler Thromb Vasc Biol. 2013;33:1153-1161.
10. Krishnan RM, Adar SD, Szpiro AA, et al. Vascular responses to longand short-term exposure to fine particulate matter: MESA Air (Multi-Ethnic Study of Atherosclerosisi and Air Pollution). J Am Coll Cardiol. 2012;60:2158-2166.
11. Muto E, Hayashi T, Yamada K, Esaki T, Sagai M, Iguchi A. Endothelial-constitutive nitric oxide synthase exists in airways and diesel exhaust particles inhibit the effect of nitric oxide. Life Sci. 1996;59: 1563-1570.
12. Zheng Z, Xu X, Zhang X, et al. Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model. J Hepatol. 2013;58:148-154.
13. Chuang KJ, Yan YH, Cheng TJ. Effect of air pollution on blood pressure, blood lipids, and blood sugar: A population-based approach. J Occup Environ Med. 2010;52:258-262.
14. Sun Q, Yue P, Deiuliis JA, et al. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation. 2009;119:538-546.
15. Li R, Navab M, Pakbin P, et al. Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice. J Lipid Res. 2013;54:1608-1615.
16. Chuang KJ, Yan YH, Chiu SY, Cheng TJ. Long-term air pollution exposure and risk factors for cardiovascular diseases among the elderly in Taiwan. Occup Environ Med. 2011;68:64-68.
17. Kim JH, Hong YC. GSTM1, GSTT1, and GSTP1 polymorphisms and associations between air pollutants and markers of insulin resistance in elderly Koreans. Environ Health Perspect. 2012;120: 1378-1384.
18. Brook RD, Xu X, Bard RL, et al. Reduced metabolic insulin sensitivity following sub-acute exposures to low levels of ambient fine particulate matter air pollution. Sci Total Environ. 2013; 448:66-71.
19. Jacobs L, Emmerechts J, Hoylaerts MF, et al. Traffic air pollution and oxidized LDL. PLoS One. 2011;6:e16200.
20. Hoek G, Beelen R, de Hoogh K, et al.A review of land-use regression models to assess spatial variation of outdoor air pollution. Atmos Environ. 2008;42:7561-7578.
21. Park JW, Lim YH, Kyung SY, et al. Effects of ambient particulate matter on peak expiratory flow rates and respiratory symptoms of asthmatics during Asian dust periods in Korea. Respirology. 2005; 10:470-476.
22. Wong CM, Vichit-Vadakan N, Kan H, Qian Z, Teams PP. Public Health and Air Pollution in Asia (PAPA): A multicity study of shortterm effects of air pollution on mortality. Environ Health Perspect. 2008;116:1195-1202.
23. Krasnov H, Katra I, Koutrakis P, Friger MD. Contribution of dust storms to PM10 levels in an urban arid environment. J Air Waste Manag Assoc. 2014;64:89-94.
24. Krasnov H, Katra I, Novack V, Vodonos A, Friger MD. Increased indoor PM concentrations controlled by atmospheric dust events and urban factors. Build Environ. 2015;87:169-176.
25. Kloog I, Chudnovsky AA, Just AC, et al. A new hybrid spatio-temporal model for estimating daily multi-year PM2.5 concentrations across northeastern USA using high resolution aerosol optical depth data. Atmos Environ. 2014;95:581-590.
26. Central Bureau of Statistics. Characterization and ranking of local authorities according to the population's socio economic level in 2008. Available at http://www.cbs.gov.il/webpub/pub/text-page.html?publ-100&CYear-2008&CMonth-1.
27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(suppl 1):S81-S90.
28. Kloog I, M. Sorek-Hamer M, Lyapustin A, et al. Estimating daily PM2.5 and PM10 across the complex geo-climate region of Israel using MAIAC satellite-based AOD data. Atmos Environ. 2015; 122:409-416.
29. Lyapustin A, Wang Y, Laszlo I, et al. Multiangle implementation of atmospheric correction (MAIAC): 2. aerosol algorithm. J Geophys Res Atmos. 2011;116.
30. Yitshak Sade M, Kloog I, Liberty IF, Katra I, Novack L, Novack V. Air pollution and serum glucose levels: A population-based study. Medicine. 2015;94:e1093.
31. O'Neill MS, Veves A, Zanobetti A, et al. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005;111:2913-2920.
32. Zanobetti A, Schwartz J. Cardiovascular damage by airborne particles: Are diabetics more susceptible? Epidemiology. 2002;13:588-592.
33. Rioux CL, Tucker KL, Brugge D, Gute DM, Mwamburi M. Traffic exposure in a population with high prevalence type 2 diabetes-do medications influence concentrations of C-reactive protein? Environ Pollut. 2011;159:2051-2060.
34. Rajagopalan S, Brook RD. Air pollution and type 2 diabetes: mechanistic insights. Diabetes. 2012;61:3037-3045.
35. Künzli N, Kaiser R, Medina S, et al. Public-health impact of outdoor and traffic-related air pollution: A European assessment. Lancet. 2000;356:795-801.
36. Raaschou-Nielsen O, Sørensen M, Ketzel M, et al. Long-term exposure to traffic-related air pollution and diabetes-associated mortality: A cohort study. Diabetologia. 2013;56:36-46.
37. Gerstein HC. Glucose: A continuous risk factor for cardiovascular disease. Diabetic Med. 1997;14:S25-S31.
38. Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993-2000.
39. Hu G, Cui Y, Jousilahti P, et al. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease. Eur J Prev Cardiol. 2013;20:89-97.
40. Heart Protection Study Collaborative G. The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20, 536 high-risk people: A randomised placebo-controlled trial ISRCTN48489393. BMC Med. 2005;3:6.
41. Block JP, Christakis NA, O'Malley AJ, Subramanian SV. Proximity to food establishments and body mass index in the Framingham Heart Study offspring cohort over 30 years. Am J Epidemiol. 2011; 174:1108-1114.